Not to be confused with Sinopharm, the short name of the parent company China National Pharmaceutical Group.
Sinopharm Group
logo of Sinopharm Group (same as China National Pharmaceutical Group), with bilingual name on the right
Company type
public
Traded as
unlisted
(A share)
SEHK: 1099
(H share)
ISIN
CNE100000FN7
Industry
Pharmaceutical
Founded
1998 (predecessor)
2003
Founder
China National Pharmaceutical Group
Headquarters
Sinopharm Plaza,
Shanghai
,
China
Area served
China
Key people
Wei Yulin (Chairman)
Chen Qiyu (Vice-Chairman)
Li Zhiming (President)
Revenue
CN¥227.069 billion (2015)
Operating income
CN¥9.169 billion (2015)
Net income
CN¥3.761 billion (2015)
Total assets
CN¥138.267 billion (2015)
Total equity
CN¥30.052 billion (2015)
Owner
Sinopharm Industrial Investment (56.79%)
Parent
Sinopharm Industrial Investment
Subsidiaries
Sinopharm CNMC
Footnotes / references in a consolidated basis; equity and profit excluded minority interests; in Hong Kong Financial Reporting Standards[1]
Sinopharm Group Co., Ltd.
Simplified Chinese
国药控股股份有限公司
Traditional Chinese
國藥控股股份有限公司
Literal meaning
Sinopharm Holding Joint-Stock Limited Company
Transcriptions
Sinopharm Group
Simplified Chinese
国药控股
Traditional Chinese
國藥控股
Literal meaning
Sinopharm Holding
Transcriptions
Second alternative Chinese name
Simplified Chinese
国控股份有限公司
Traditional Chinese
國控股份有限公司
Transcriptions
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009,[2] with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list.[3]
^"2015 Annual Report" (PDF). Sinopharm Group. Hong Kong Stock Exchange. 25 April 2016. Retrieved 22 November 2016.
^"China's Sinopharm gets OK for $1 bln HK IPO". Reuters. 2009-07-29. Retrieved 2020-11-14.
SinopharmGroup Co., Ltd. is a Chinese pharmaceutical company. The parent company of SinopharmGroup was Sinopharm Industrial Investment, a 51–49 joint...
acquired 49% stake of SinopharmGroup (Chinese: 国药控股).: 30 In 2008, a year before the initial public offering of SinopharmGroup, Fosun Pharmaceutical...
All For Health Health For All: Annual Report 2020 (PDF) (Report). SinopharmGroup Co. Ltd. 2020. "Archived copy" (PDF). Archived from the original (PDF)...
SEHK: 1093 CSPC Pharmaceutical Group Commerce & Industry SEHK: 1099 SinopharmGroup Commerce & Industry SEHK: 1177 Sino Biopharm Commerce & Industry SEHK: 1211...
by revenue". Fortune. Retrieved 19 January 2024. "China National Erzhong Group Co., Ltd.: Private Company Information". Bloomberg. Retrieved 25 November...
terms of sales, China's top three companies: SinopharmGroup, Shanghai Pharmaceutical Co. and Jiuzhoutong Group Corp., are all shared less than 5% of the...
Group B streptococcal infection, also known as Group B streptococcal disease or just Group B strep infection, is the infectious disease caused by the bacterium...
subsidiary of China National Pharmaceutical Group, a Chinese state-owned enterprise commonly known as Sinopharm. The institute integrates production, education...
former president Martín Vizcarra's secret COVID-19 vaccination with SinopharmGroup in September 2020 while Peruvians struggled due to the COVID-19 pandemic...
In countries with a low risk of disease, they recommend that high risk groups should be immunized. In the African meningitis belt efforts to immunize...
2021, a rebranded version of the Chinese Sinopharm BIBP vaccine through a joint venture between Sinopharm and Group 42, the country has donated vaccine doses...
company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical...
Global 500, ranked behind other pharmaceutical companies China Resources, Sinopharm, Johnson & Johnson, Pfizer, Roche, AbbVie, Novartis, Bayer, and Merck...
Global Information
CN¥227.069 billion (2015)